Back to Capital World Investors

AZN

2 quarters

Position history for Capital World Investors's holdings in ASTRAZENECA PLC

Yes. Capital World Investors holds 30,075,134 shares of AZN (AstraZeneca), worth $5.6B, as of its Q2 2026 13F filing. It increased the position by 1,810,554 shares (+6.4%) from Q1 2026. Capital World Investors has held AZN in every 13F on record since Q1 2026, 2 quarterly filings. AZN is 0.7% of Capital World Investors' reported 13F portfolio.

Other major holders of AZN: VANGUARD CAPITAL MANAGEMENT LLC, Capital International Investors, NORGES BANK